BAX logo

Baxter International (BAX)

Profile

Full Name

Baxter International Inc.

Ticker Symbol

BAX

Exchange

NYSE

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

October 27, 1981

Indexes

S&P 500

Website

http://www.baxter.com

Employees

38000

Key Details

Price

$27.80(-2.04%)

Market cap

Last Dividend

$0.17

TTM Dividend yield

3.31%

Annual revenue

$10.64B(+2.66% YoY)

Annual EPS

-$1.27(-124.28% YoY)

PE ratio

-

Next earnings date

May 2, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$27.80
BAX price is $27.80

30-Day Relative Volume

1.06
BAX 30-day relative volume is 1.06

Price Performance

Price Today change

-2.04%
BAX price is down -2.04% today

Price YTD change

-4.66%
BAX price is down -4.66% since January 1st

Price 1-year change

-30.57%
BAX price is down -30.57% year-on-year

Price 3-year change

-63.63%
BAX price is down -63.63% over the past 3 years

Price Range

Price All-time high

$95.19
BAX price is currently -70.80% below its historical high of $95.19

Price 3-year low

$26.25
BAX price is currently +5.90% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$14.22B
BAX market capitalization is $14.22 billion

Market cap 3-year change

-63.04%
BAX market capitalization is down -63.04% over the past 3 years

Market cap All-time high

$47.86B
BAX market capitalization is currently -70.28% below its historical high of $47.86 billion

Market cap sector rank

94.74%
BAX market capitalization is higher than 94.74% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.4%
BAX shares outstanding is up +0.4% year-on-year

Shares Outstanding 3-Year Change

+1.63%
BAX shares outstanding is up +1.63% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.69
BAX beta is 0.69

200-day SMA

$34.14
BAX price is currently -18.57% below its 200-day simple moving average

50-day SMA

$32.69
BAX price is currently -14.95% below its 50-day simple moving average

RSI

33.88
BAX 14-day relative strength index is 33.88

Volume

1.06
BAX 30-day relative volume is 1.06

ATR

$1.55
BAX average true range is $1.55

10-day Historical Volatility

86.23%
BAX 10-day historical volatility is 86.23%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.17
BAX last dividend was $0.17 per share, with an ex-dividend date of February 28, 2025

Next Dividend

-
BAX next dividend has not yet been announced

Dividend per share

Dividend per share

$1.04
BAX annual dividend per share is $1.04

Dividend per share Sector Rank

43.02%
BAX annual dividend per share is higher than 43.02% of companies in Healthcare sector

Dividend per share 1-Year Change

-10.34%
BAX annual dividend per share is down -10.34% year-on-year

Dividend per share 3-Year Change

-4.15%
BAX annual dividend per share is down -4.15% over the past 3 years

Dividend yield

Dividend yield

3.74%
BAX annual dividend yield is 3.74%

Dividend yield Sector Rank

71.76%
BAX annual dividend yield is higher than 71.76% of companies in Healthcare sector

Other

Payout ratio

-90.91%
BAX annual payout ratio is -90.91%

Dividends paid

$590.00M
BAX annual dividends paid is $590.00 million

Free cash flow

$559.00M
BAX annual free cash flow is $559.00 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$10.64B
BAX annual revenue is $10.64 billion

Revenue Analysts estimate

$11.20B
BAX annual revenue is currently -5.06% lower than the consensus analysts' forecast

Revenue 1-year change

+2.66%
BAX annual revenue is up +2.66% year-on-year

Revenue Sector rank

94.4%
BAX annual revenue is higher than 94.4% of companies in Healthcare sector

EPS

EPS

-$1.27
BAX annual earnings per share is -$1.27

EPS Analysts estimate

$2.49
BAX annual earnings per share is currently -150.97% lower than the consensus analysts' forecast

EPS 1-year change

-124.28%
BAX annual earnings per share is down -124.28% year-on-year

EPS Sector rank

50.62%
BAX annual earnings per share is higher than 50.62% of companies in Healthcare sector

Profit

Gross profit

$3.98B
BAX annual gross profit is $3.98 billion

Gross margin

37.46%
BAX annual gross profit margin is 37.46%

Operating profit

$439.00M
BAX annual operating income is $439.00 million

Operating margin

4.13%
BAX annual operating profit margin is 4.13%

Net income

-$649.00M
BAX annual net profit is -$649.00 million

Net margin

-6.10%
BAX annual net profit margin is -6.10%

Expenses

Total expenses

$10.20B
BAX annual total expenses is $10.20 billion

Operating expenses

$3.54B
BAX annual total operating expenses is $3.54 billion

Cost of goods sold

$6.65B
BAX annual cost of goods sold is $6.65 billion

Selling, general & administrative expenses

$2.97B
BAX annual SGA is $2.97 billion

Depreciation and amortization

$997.00M
BAX annual depreciation & amortization is $997.00 million

Interest expense

$408.00M
BAX annual interest expense is $408.00 million

Income tax

$37.00M
BAX annual income tax is $37.00 million

EBIT & EBITDA

EBIT

$52.00M
BAX annual earnings before interest & taxes is $52.00 million

EBITDA

$52.00M
BAX annual EBITDA is $52.00 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$25.78B
BAX annual total assets is $25.78 billion

Non current assets

$16.93B
BAX annual long term assets is $16.93 billion

Current assets

$8.85B
BAX annual total current assets is $8.85 billion

Cash and cash equivalents

$1.76B
BAX annual cash & cash equivalents is $1.76 billion

Accounts receivable

$1.68B
BAX annual accounts receivable is $1.68 billion

Inventory

$2.05B
BAX annual inventory is $2.05 billion

Liabilities

Total liabilities

$18.76B
BAX annual total liabilities is $18.76 billion

Long term liabilities

$12.25B
BAX annual total long term liabilities is $12.25 billion

Current liabilities

$6.51B
BAX annual total current liabilities is $6.51 billion

Accounts payable

$968.00M
BAX annual accounts payable is $968.00 million

Debt

Total debt

$13.45B
BAX annual total debt is $13.45 billion

Total debt 1-year change

-4.7%
BAX annual total debt is down -4.7% year-on-year

Long term debt

$10.62B
BAX annual long term debt is $10.62 billion

Short term debt

$2.83B
BAX annual short term debt is $2.83 billion

Equity & Capital

Shareholders equity

$6.96B
BAX annual stockholders equity is $6.96 billion

Book value

$6.96B
BAX annual book value is $6.96 billion

Retained earnings

$14.93B
BAX annual retained earnings is $14.93 billion

Working capital

$2.34B
BAX annual working capital is $2.34 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$1.02B
BAX annual cash flow from operations is $1.02 billion

Cash from operations 1-year change

-40.96%
BAX annual cash flow from operations is down -40.96% year-on-year

Cash from investing

-$626.00M
BAX annual cash flow from investing activities is -$626.00 million

Cash from investing 1-year change

-119.48%
BAX annual cash flow from investing activities is down -119.48% year-on-year

Cash from financing

-$1.08B
BAX annual cash flow from financing activities is -$1.08 billion

Cash from financing 1-year change

+69.02%
BAX annual cash flow from financing activities is up +69.02% year-on-year

CAPEX

CAPEX

$460.00M
BAX annual capital expenditures is $460.00 million

CAPEX 1-year change

+5.5%
BAX annual capital expenditures is up +5.5% year-on-year

Free Cash Flow

Free cash flow

$559.00M
BAX annual free cash flow is $559.00 million

Free cash flow 1-year change

-56.67%
BAX annual free cash flow is down -56.67% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

37.46%
BAX annual gross profit margin is 37.46%

Operating margin

4.13%
BAX annual operating profit margin is 4.13%

Net margin

-6.10%
BAX annual net profit margin is -6.10%

ROA & ROE

ROA

-2.40%
BAX annual return on assets is -2.40%

ROE

-8.38%
BAX annual return on equity is -8.38%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
BAX price to earnings ratio value is unknown

PE ratio Sector rank

-
BAX price to earnings ratio is unknown

PB Ratio

PB ratio

2.04
BAX price to book ratio is 2.04

PB ratio Sector rank

62.63%
BAX price to book ratio is higher than 62.63% of companies in Healthcare sector

PS Ratio

PS ratio

1.11
BAX price to sales ratio is 1.11

PS ratio Sector rank

29.1%
BAX price to sales ratio is higher than 29.1% of companies in Healthcare sector

Enterprise value

Enterprise value

$25.91B
BAX enterprise value is $25.91 billion

Enterprise value Sector rank

96.03%
BAX enterprise value is higher than 96.03% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

46.51
BAX EV/EBITDA is 46.51

EV/EBITDA Sector rank

96.96%
BAX EV/EBITDA is higher than 96.96% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.36
BAX annual current ratio is 1.36

Quick ratio

1.05
BAX annual quick ratio is 1.05

Leverage

Debt to equity

1.88
BAX annual debt to equity ratio is 1.88

Interest coverage ratio

0.13
BAX annual interest coverage ratio is 0.13

Risk & Stability

Piotroski F-Score

4
BAX piotroski f-score is 4

Altman Z-Score

1.79
BAX altman z-score is 1.79

Analyst ratings

Recent major analysts updates

Mar 10, 25 Barclays
Overweight
Feb 21, 25 JP Morgan
Neutral
Dec 11, 24 Citigroup
Neutral
Nov 11, 24 Stifel
Buy
Oct 1, 24 Citigroup
Neutral
Aug 8, 24 Goldman Sachs
Neutral
Aug 7, 24 Wells Fargo
Equal-Weight
Aug 7, 24 JP Morgan
Neutral
Jul 15, 24 Morgan Stanley
Underweight
Jul 11, 24 Citigroup
Neutral

Institutional Ownership

Similar stocks

RPRX logo
Royalty Pharma (RPRX)
ITCI logo
Intra-Cellular Therapies (ITCI)
FMS logo
Fresenius Medical Care AG & Co KGaA (FMS)
WST logo
West Pharmaceutical Services (WST)
HOLX logo
Hologic (HOLX)
COO logo
Cooper Companies (COO)
INSM logo
Insmed Incorporated (INSM)
TEVA logo
Teva Pharmaceutical Industries Limited (TEVA)
UTHR logo
United Therapeutics (UTHR)
  • What is the ticker symbol for Baxter International?
  • Does Baxter International pay dividends?
  • What sector is Baxter International in?
  • What industry is Baxter International in?
  • What country is Baxter International based in?
  • When did Baxter International go public?
  • Is Baxter International in the S&P 500?
  • Is Baxter International in the NASDAQ 100?
  • Is Baxter International in the Dow Jones?
  • When was Baxter International's last earnings report?
  • When does Baxter International report earnings?
  • Should I buy Baxter International stock now?

What is the ticker symbol for Baxter International?

The ticker symbol for Baxter International is NYSE:BAX

Does Baxter International pay dividends?

Yes, Baxter International pays dividends. The last payment was $0.17, with an ex-dividend date on February 28, 2025

What sector is Baxter International in?

Baxter International is in the Healthcare sector

What industry is Baxter International in?

Baxter International is in the Medical Instruments & Supplies industry

What country is Baxter International based in?

Baxter International is headquartered in United States

When did Baxter International go public?

Baxter International's initial public offering (IPO) was on October 27, 1981

Is Baxter International in the S&P 500?

Yes, Baxter International is included in the S&P 500 index

Is Baxter International in the NASDAQ 100?

No, Baxter International is not included in the NASDAQ 100 index

Is Baxter International in the Dow Jones?

No, Baxter International is not included in the Dow Jones index

When was Baxter International's last earnings report?

Baxter International's most recent earnings report was on Feb 20, 2025

When does Baxter International report earnings?

The next expected earnings date for Baxter International is May 2, 2025

Should I buy Baxter International stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page